ReviewAdvances in therapy2024

Potential Underlying Mechanisms Explaining the Cardiorenal Benefits of Sodium-Glucose Cotransporter 2 Inhibitors.

Subodh Verma et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.